News

Innovation alliance unveils new name and strategic plan for Western Virginia

A strategic alliance has a new name — Verge — and a new vision of acting as the front door for an innovation economy that stretches from Lynchburg to the New River Valley.

Formed last year, the alliance is a joint mission of the Valleys Innovation Council, the Roanoke-Blacksburg Technology Council and the Regional Accelerator and Mentoring Program, known as RAMP.

At a virtual news conference Monday, organizers said the unified strength of the three organizations will help solidify connections and better leverage emerging opportunities for the region’s technologists, innovators and entrepreneurs.

Verge will focus on the technology and life sciences innovation ecosystem in the GO Virginia Region 2, a sprawling span of the state that includes the Roanoke and New River valleys, the Alleghany Highlands and the Lynchburg region.

“What is happening in technology in this part of Virginia is really exciting,” CEO Greg Feldmann said in a statement.

“By aligning the efforts of three distinct but synergistic entities, we will all more effectively develop external resourcing, more efficiently implement new programs ensuring each reaches the right audiences at the right moments and in the right contexts to provide maximum value.

“It’s all about comprehensively supporting the many people and organizations who are investing in and shaping the economic future of our region.”

While collaborating in the newly defined joint mission, the three organizations will continue their day-to-day operations under the same leadership.

Recent News

12/19/2024

Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today announces FDA clearance to initiate a new additional Netherton Syndrome (NS) clinical study for QRX003. QRX003 is a topical lotion that contains a broad-spectrum serine protease inhibitor designed to target the kallikreins in

12/11/2024

Liquet™ Medical Inc. Receives FDA 510(k) Clearance for the Versus™ Catheter

Liquet Medical Inc., a pioneering medical device company committed to advancing patient care through innovative technologies, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Versus™ Catheter. This innovative medical device is set to enhance the treatment of pulmonary artery blood clots by offering real-time pulmonary artery

12/03/2024

ivWatch Named to Inc.’s 2024 Best in Business List in Health Products Category

ivWatch, LLC, the IV safety company, is proud to announce it has been named to the Inc. 2024 Best in Business list in the Health Products category. Inc.’s annual Best in Business Awards celebrate the exceptional achievements and contributions of companies that have made a profound impact on their industries and on society at large.